Evidence map›Paper›PMID 41331088›Full record

ArticleNature cell biology2025

Karyopherins remodel the dynamic organization of the nuclear pore complex transport barrier.

Toshiya Kozai, Javier Fernandez-Martinez, Larisa E Kapinos, Paola Gallardo, Trevor van Eeuwen, Martin Saladin, Roi Eliasian, Adam Mazur, Wenzhu Zhang, Jeremy Tempkin and 11 more

Abstract read
In one paragraph

Article in Nature cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Toshiya Kozai *Biozentrum, University of Basel, Basel, Switzerland.
Javier Fernandez-Martinez *Laboratory of Cellular and Structural Biology, The Rockefeller University, New York, NY, USA.
Larisa E KapinosBiozentrum, University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0001-6101-0876
Paola GallardoEuropean Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.ORCID http://orcid.org/0000-0002-8801-0355
Trevor van EeuwenLaboratory of Cellular and Structural Biology, The Rockefeller University, New York, NY, USA.ORCID http://orcid.org/0000-0003-0549-1702
Martin SaladinBiozentrum, University of Basel, Basel, Switzerland.
Roi EliasianSchool of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.
Adam MazurBiozentrum, University of Basel, Basel, Switzerland.
Wenzhu ZhangLaboratory of Mass Spectrometry and Gaseous Ion Chemistry, The Rockefeller University, New York, NY, USA.
Jeremy TempkinDepartment of Bioengineering and Therapeutic Sciences, University of California, San Franscisco, San Francisco, CA, USA.
Radhakrishnan PanatalaBiozentrum, University of Basel, Basel, Switzerland.
Maria Delgado-IzquierdoInstituto Biofisika (UPV/EHU, CSIC) and Fundacion Biofisica Bizkaia/Biofisika Bizkaia Fundazioa (FBB), University of the Basque Country, Leioa, Spain.ORCID http://orcid.org/0009-0002-8821-5809
Raul Escribano-MarinInstituto Biofisika (UPV/EHU, CSIC) and Fundacion Biofisica Bizkaia/Biofisika Bizkaia Fundazioa (FBB), University of the Basque Country, Leioa, Spain.
Qingzhou FengNanobiology Institute, Yale University, West Haven, CT, USA.
Chenxiang LinNanobiology Institute, Yale University, West Haven, CT, USA.ORCID http://orcid.org/0000-0001-7041-1946
Andrej SaliDepartment of Bioengineering and Therapeutic Sciences, University of California, San Franscisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-0435-6197
Brian T ChaitLaboratory of Mass Spectrometry and Gaseous Ion Chemistry, The Rockefeller University, New York, NY, USA.ORCID http://orcid.org/0000-0003-3524-557X
Barak RavehSchool of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.
Liesbeth M VeenhoffEuropean Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.ORCID http://orcid.org/0000-0002-0158-4728
Michael P RoutLaboratory of Cellular and Structural Biology, The Rockefeller University, New York, NY, USA. rout@mail.rockefeller.edu.ORCID http://orcid.org/0000-0003-2010-706X
Roderick Y H LimBiozentrum, University of Basel, Basel, Switzerland. roderick.lim@unibas.ch.ORCID http://orcid.org/0000-0001-5015-6087

Funding

TR&D Project 4. The Imaging Stage: Multiscale Spatiotemporal Modeling of Macromolecular Systems in Cellular NeighborhoodsP41GM109824 · NIGMS · ROCKEFELLER UNIVERSITY · PI ROUT, MICHAEL P · 2014 to 2023
$18.8M
Structure-Function Mapping of the Nuclear Pore Complex-RenewalR01GM112108 · NIGMS · ROCKEFELLER UNIVERSITY · PI JOHN D. AITCHISON, MICHAEL P ROUT · 2015 to 2026
$9.1M
IMP: Software for Hybrid Determination of Macromolecular Assembly StructuresR01GM083960 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SALI, ANDREJ · 2008 to 2024
$5.2M
The dynamic mechanism of nuclear transport visualized at the atomic scaleR01GM117212 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI COWBURN, DAVID · 2016 to 2023
$3.7M
A multiscale approach for elucidating nuclear entry mechanisms of HIV-1 capsidR01AI162260 · NIAID · YALE UNIVERSITY · PI LIN, CHENXIANG, XIONG, YONG · 2021 to 2025
$3.5M
Israel Science Foundation (ISF) 385/24National Science Foundation (NSF) 1818129Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organisation for Scientific Research) OCENW.GROOT.2019.068Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organisation for Scientific Research) VI.C.192.031NIAID NIH HHS R01 AI162260NIGMS NIH HHS P41 GM109824NIGMS NIH HHS R01 GM083960NIGMS NIH HHS R01 GM112108NIGMS NIH HHS R01 GM117212Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 310030_201062Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) IZCOZ0_220223U.S. Department of Health & Human Services | National Institutes of Health (NIH) NIH P41 GM109824U.S. Department of Health & Human Services | National Institutes of Health (NIH) NIH R01 AI162260U.S. Department of Health & Human Services | National Institutes of Health (NIH) NIH R01 GM083960U.S. Department of Health & Human Services | National Institutes of Health (NIH) NIH R01 GM112108U.S. Department of Health & Human Services | National Institutes of Health (NIH) NIH R01 GM117212
6 · The paper itself

Abstract

Nuclear pore complexes (NPCs) mediate selective exchange of macromolecules between the nucleus and cytoplasm, but the organization of their transport barrier has been a matter of debate. Here we used high-speed atomic force microscopy, complemented with orthogonal in vitro and in vivo approaches, to probe the dynamic behaviour of the NPC central channel at millisecond resolution. We found that nuclear transport factors dynamically remodel intrinsically disordered phenylalanine-glycine (FG) domains tethered within the NPC channel, partitioning the barrier into two zones: a rapidly fluctuating annular region and a highly mobile central plug. Increased FG-repeat density in mutant NPCs dampened barrier dynamics and impaired transport. Notably, NPC-like behaviour was recapitulated in DNA origami nanopores bearing transport factors and correctly tethered FG domains but not in in vitro FG hydrogels. Thus, the rotationally symmetric architecture of NPCs supports a nanoscopic barrier organization that contrasts with many of the bulk properties of in vitro FG-domain assemblies.

Indexed as

KaryopherinsNuclear PoreNuclear Pore Complex ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsActive Transport, Cell NucleusCell NucleusHumansMicroscopy, Atomic ForceNanoporesPhenylalanineKaryopherinsNuclear Pore Complex ProteinsPhenylalanineSaccharomyces cerevisiae Proteins

Identifiers

PMID41331088
PMCPMC12717009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.